FdaApplication
ANDA 210924
Identifiers
- fda_app_no: ANDA210924
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2020-06-19 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHYLPHENIDATE | METHYLPHENIDATE | 8.6MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL |
| METHYLPHENIDATE | METHYLPHENIDATE | 17.3MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL |
| METHYLPHENIDATE | METHYLPHENIDATE | 25.9MG | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL |
3 products